72 episodes

The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.

NEI Podcast Neuroscience Education Institute

    • Medicine
    • 4.2, 32 Ratings

The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.

    Disparities, Disease, and Desperation: The Impact of COVID-19 on Physical and Mental Health in Black Americans

    Disparities, Disease, and Desperation: The Impact of COVID-19 on Physical and Mental Health in Black Americans

    Healthcare disparities occur around the world, due to a complex, multifaceted situation that results from socioeconomic hardships, psychosocial stress, and cultural differences. In the United States, these disparities are often seen in minority communities, such as Hispanics and Black Americans. When a pandemic, such as COVID-19 occurs, it can expose these disparities in the most tragic ways. Current statistics surrounding healthcare disparities during the pandemic are staggering, suggesting that COVID-19 has disproportionately impacted the Black American community. In this important and timely interview with Dr. Napoleon Higgins, we address your most pressing questions on why this is occurring, and how awareness can improve this situation for future generations.
    Dr. Napoleon Higgins, Jr., is a psychiatrist in the Houston/Clear Lake City Area. He currently serves as Owner, CEO and President of Bay Pointe Behavioral Health Service, Inc., and South East Houston Research Group, Inc. He also practices as the Medical Director of Hold My Hand Residential Treatment Center. Dr. Higgins specializes in treating mental health disorders through medication management, psychotherapy and behavioral training.

    • 36 min
    (CME) More Than Meets the Mouth! Important Interactions Between Food, Beverages, and Psychiatric Medications with Dr. Raj Mago

    (CME) More Than Meets the Mouth! Important Interactions Between Food, Beverages, and Psychiatric Medications with Dr. Raj Mago

    Food and beverages interact with certain psychiatric medications to alter their pharmacokinetic properties, resulting in potentially unintended health outcomes. In this podcast episode, Dr. Rajnish Mago describes common food and beverages that interact with psychiatric medication and provides recommendations for avoiding unintended food-drug interactions.
    Optional CME credits / certificate instructions: After listening to the podcast, to take the optional posttest and receive CME credit, click HERE.
     Learning Objectives: After completing this educational activity, you should be better able to:
    Describe the effects of food on the bioavailability of certain psychotropic medications Discuss current evidence of the brain-gut connection’s impact on mental health Describe the effects of vitamin C, caffeine, and grapefruit on the pharmacokinetics of certain psychotropic medications  Accreditation and Credit Designation Statements: The Neuroscience Education Institute (NEI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    NEI designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A posttest score of 70% or higher is required to receive CME credit.
     Nurses and Physician Assistants: for your CE requirements, the ANCC and NCCPA will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content in this activity pertains to pharmacology and is worth 0.75 continuing education hour of pharmacotherapeutics.
     Peer Review: The content was peer-reviewed by a PharmD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME activity.
     Disclosures: All individuals in a position to influence or control content are required to disclose all relevant financial relationships. Although potential conflicts of interest are identified and resolved prior to the activity being presented, it remains for the participant to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.
     Faculty Interviewer / Author
    Andrew J. Cutler, MD   
    Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY
    Grant/Research: Acadia, Alkermes, Allergan, Axsome, Biohaven, Intra-Cellular, Lundbeck, Novartis, Otsuka, Sage, Sunovion, Tris  
    Consultant/Advisor: Acadia, AiCure, Alfasigma, Alkermes, Allergan, Avanir, Intra-Cellular, Ironshore, Janssen, Lundbeck, MedAvante-ProPhase, Neurocrine, Novartis, Otsuka, Sage, Sunovion, Takeda, Teva, Tris
    Speakers Bureau: Acadia, Alkermes, Allergan, Avanir, Ironshore, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Takeda, Teva, Tris
    Faculty Interviewee / Author
    Rajnish Mago, MD
    Clinical Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY
    Speakers Bureau: Intas
    Stockholder: Johnson and Johnson
     Pre-Interview Author
    Sabrina K. Bradbury-Segal, PhD
    Medical Writer, Neuroscience Education Institute, Carlsbad, CA
    No financial relationships to disclose.
     The Planning Committee and Peer Reviewer have no financial relationships to disclose.
     Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.
     Cultural and Linguistic Competency: A variety of resources addressing cultural and linguistic competency can be found in this linked handout.

    • 33 min
    A Beacon of Hope in the Storm of Mental Illness: An Update on Suicide Awareness and Prevention with Dr. Christine Moutier

    A Beacon of Hope in the Storm of Mental Illness: An Update on Suicide Awareness and Prevention with Dr. Christine Moutier

    With the recent COVID-19 pandemic, mental health concerns are on the rise. What do we know about the relationship between suicide risk and previous pandemics or natural disasters? How do we distinguish between behavior that seems like appropriate coping during this time and behavior that should raise a red flag? What are some protective factors against suicide, and how can we capitalize on these, especially during this challenging time?  Join us, as we interview the Chief Medical Officer of the American Foundation for Suicide Prevention (AFSP), Dr. Christine Moutier.
    Dr. Moutier knows the impact of suicide firsthand. After losing colleagues to suicide, she dedicated herself to fighting this leading cause of death. Throughout her career she has focused on fighting stigma related to mental health and help seeking. Training healthcare leaders, physicians, and advocacy groups, Dr. Moutier has sought to change the healthcare system’s approach to mental health, in order to optimize care for those suffering from mental health conditions.
    As a leader in the field of suicide prevention, Dr. Moutier joined AFSP in 2013, and has revitalized AFSP’s Education team, re-launched its Loss & Healing department, and expanded AFSP’s support to include those with lived experience of suicide.
    Moutier has authored articles and book chapters for publications such as the Journal of the American Medical Association, Academic Medicine, the American Journal of Psychiatry, the Journal of Clinical Psychiatry, Psychiatric Times, Depression and Anxiety, and Academic Psychiatry.
    She has testified before the U.S. Congress and spoken at the White House, she was the host of AFSP’s documentary on surviving suicide loss, The Journey, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, the BBC, NBC, CNN, and other print and television outlets.
    You can follow Dr. Moutier on Twitter at @cmoutierMD.
    For more information on the AFSP please visit: asfp.org

    • 40 min
    Move It Or Lose It! An Update on Exercise and the Brain with Dr. John Ratey

    Move It Or Lose It! An Update on Exercise and the Brain with Dr. John Ratey

    What is the evidence that exercise is at least as effective as medications for the treatment of mental health disorders, such as depression? Can you share any research findings on the effects of exercise for patients with traumatic brain injury?  If you have questions like these, you won't want to miss this episode with psychiatrist and renowed author, Dr. John Ratey!
    Best selling author, John J. Ratey, MD, is an Associate Clinical Professor of Psychiatry at Harvard Medical School and an internationally recognized expert in Neuropsychiatry. He has published over 60 peer-reviewed articles, and 11 books published in 17 languages, including the groundbreaking ADD-ADHD “Driven to Distraction” series with Ned Hallowell, MD. With the publication of  "Spark-The Revolutionary New Science of Exercise and the Brain," Dr. Ratey has established himself as one of the world's foremost authorities on the brain-fitness connection.  His most recent book, “Go Wild” explores how we can achieve optimal physical and mental health by getting in touch with our caveman roots, and how we can “re-wild” our lives.

      Recognized by his peers as one of the Best Doctors in America since 1997, Dr. Ratey was recently honored by the Massachusetts Psychiatric Society as "Outstanding Psychiatrist of the Year" for advancing the field. Dr. Ratey and his work are frequently profiled in the media, where he’s been featured on ABC, CBS, NBC, PBS and NPR, as well as in The New York Times, Newsweek, The Washington Post, US News and World Report, Men’s Health, and other national publications.

    • 27 min
    Pediatric Anxiety in the Midst of a Pandemic with Dr. Jeffrey Strawn

    Pediatric Anxiety in the Midst of a Pandemic with Dr. Jeffrey Strawn

    Given the recent COVID-19 virus pandemic, how is pediatric anxiety influenced by things like the media, parental attitudes, and the family environment? How effective is telepsychiatry for pediatric patients? If you have these types of questions you won't want to miss this timely and important interview with psychiatrist Dr. Jeffrey Strawn! In this episode, we discuss issues like effective communication strategies for parents during this time, and how to best meet the needs of pediatric patients with anxiety.
    Dr. Strawn is an Associate Professor of Psychiatry and Pediatrics at the University of Cincinnati and at Cincinnati Children’s Hospital. He directs the University of Cincinnati Anxiety Disorders Research Program. His ongoing research explores the pathophysiology and psychopharmacology of anxiety disorders, using functional neuroimaging and magnetic resonance spectroscopy. His research further aims to identify early predictors of treatment response in anxiety and to identify which patients may respond best to which specific treatments. In his clinical practice, he works with youth with anxiety disorders and with their parents and families. 

    • 29 min
    (CME) Gut Check: An Update on the Microbiome, Mental Health, and the Brain-Gut Connection with Dr. Roger McIntyre

    (CME) Gut Check: An Update on the Microbiome, Mental Health, and the Brain-Gut Connection with Dr. Roger McIntyre

    What is our current understanding of the gut-brain connection? What is the difference between the microbiome and microbiota? How is dysbyosis of the gut associated with certain psychiatric disorders?
    In this CME podcast, we address these questions and more in this captivating interview between Dr. Andrew J. Cutler and Dr. Roger S. McIntyre!
    Optional CME credits / certificate instructions: After listening to the podcast, to take the optional posttest and receive CME credit, click HERE.
    Learning Objectives: After completing this educational activity, you should be better able to:
    Explore the relationship between the brain-gut-microbiome axis and chronic inflammation Discuss current evidence of the brain-gut connection’s impact on mental health Consider potential implications of the gut-brain connection for the treatment of various mental illnesses Accreditation and Credit Designation Statements: The Neuroscience Education Institute (NEI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    NEI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. A posttest score of 70% or higher is required to receive CME credit.
    Nurses and Physician Assistants: for your CE requirements, the ANCC and NCCPA will accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content in this activity pertains to pharmacology and is worth 1.0 continuing education hour of pharmacotherapeutics.
    Peer Review: The content was peer-reviewed by an MD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME activity.
    Disclosures: All individuals in a position to influence or control content are required to disclose all relevant financial relationships. Although potential conflicts of interest are identified and resolved prior to the activity being presented, it remains for the participant to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.
    Faculty Interviewer / Author
    Andrew J. Cutler, MD
    Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY
    Grant/Research: Acadia, Alkermes, Allergan, Axsome, Biohaven, Intra-Cellular, Lundbeck, Novartis, Otsuka, Sage, Sunovion, Tris
    Consultant/Advisor: Acadia, AiCure, Alfasigma, Alkermes, Allergan, Avanir, Intra-Cellular, Ironshore, Janssen, Lundbeck, MedAvante-ProPhase, Neurocrine, Novartis, Otsuka, Sage, Sunovion, Takeda, Teva, Tris
    Speakers Bureau: Acadia, Alkermes, Allergan, Avanir, Ironshore, Janssen, Lundbeck, Neurocrine, Otsuka, Sunovion, Takeda, Teva, Tris
    Faculty Interviewee / Author
    Roger S. McIntyre, MD, FRCPC
    Professor, Departments of Psychiatry and of Pharmacology; Head, Mood Disorders Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada
    Grant/Research: CIHR/GACD/Chinese National Natural Research Foundation, Stanley Medical Research Institute
    Consultant/Advisor: Allergan, Janssen, Lundbeck, Minerva, Neurocrine, Otsuka, Pfizer, Purdue, Shire, Sunovion, Takeda
    Speakers Bureau: Allergan, Janssen, Lundbeck, Minerva, Neurocrine, Otsuka, Pfizer, Purdue, Shire, Sunovion, Takeda
    Pre-Interview Author
    Sabrina K. Bradbury-Segal, PhD
    Medical Writer, Neuroscience Education Institute, Carlsbad, CA
    No financial relationships to disclose.
    The Planning Committee and Peer Reviewer have no financial relationships to disclose.
    Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigat

    • 47 min

Customer Reviews

4.2 out of 5
32 Ratings

32 Ratings

ACNP Baltimore ,

Incredibly useful information

This podcast knocks it out of the park
As a prescriber that sees children and deals with the legalization of marijuana happening around them I really appreciate the talk on the actual properties and consequences of marijuana

Homebody1234 ,

NEI podcast

I am glad to have another product from NEI. I would like to see these occur with more frequency and to have longer podcasts that address clinical issues in more depth.

Marianco ,

Looks like a dead podcast

The last episode was in August 2011. Perhaps Dr. Stahl lost interest. Sad.

Top Podcasts In Medicine

Listeners Also Subscribed To